Drug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21.

ABSTRACT: We report the discovery of drug-like small molecules that bind specifically to the precursor of the oncogenic and pro-inflammatory microRNA-21 with mid-nanomolar affinity. The small molecules target a local structure at the Dicer cleavage site and induce distinctive structural changes in the RNA, which correlate with specific inhibition of miRNA processing. Structurally conservative single nucleotide substitutions eliminate the conformational change induced by the small molecules, which is also not observed in other miRNA precursors. The most potent of these compounds reduces cellular proliferation and miR-21 levels in cancer cell lines without inhibiting kinases or classical receptors, while closely related compounds without this specific binding activity are inactive in cells. These mole

SUBMITTER: Shortridge MD 

PROVIDER: S-EPMC10593481 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature